Pramlintide
CAS :
Ref. 3D-FP156979
Informations sur le produit
Nom:Pramlintide
Marque:Biosynth
Description :Pramlintide is a synthetic, short-acting insulinotropic peptide that has been shown to reduce postprandial glucagon secretion and delay gastric emptying. It also has a number of physiological effects, including the activation of ATP-sensitive potassium channels, inhibition of oxidative phosphorylation, and induction of mitochondrial membrane potential. Pramlintide is approved for use in the treatment of type 1 and type 2 diabetes mellitus. The drug binds to the glucagon receptor on pancreatic alpha cells and stimulates insulin release from beta cells in a glucose-dependent manner. Pramlintide has been shown to have no significant effect on glycemic control when used as an adjunct to insulin therapy in patients with type 2 diabetes mellitus. This drug may also cause hypoglycemia when used alone or with other antihyperglycemic agents such as sulfonylureas or meglitinides.
Avis:Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Propriétés chimiques
Masse moléculaire :3,949.39 g/mol
Formule :C171H267N51O53S2
Degré de pureté :Min. 95%
Couleur/Forme :White To Off-White Solid